| Patients with symptoms of NGU | Patients without symptoms of NGU | |||||
| PMNL/HPF | PMNL/HPF | |||||
| 0–9 | >9 | OR (CI) | 0–9 | >9 | OR (CI) | |
| Chlamydia trachomatis positive | 58 (9%) | 560 (91%) | 9.8 (7.4 to 13) | 75 (20%) | 296 (80%) | 6.6 (5.1 to 8.6) |
| Mycoplasma genitalium positive | 37 (18%) | 170 (82%) | 4.7 (3.2 to 6.7) | 38 (35%) | 69 (65%) | 3.1 (2 to 4.6) |
| M genitalium and C trachomatis negative | 1108 (50%) | 1091 (50%) | 3085 (63%) | 1837 (37%) | ||
PMNLs/HPF, polymorphic mononuclear leucocytes per high-power field.